Abstract
Background:The objective of this study was to assess the etiology, microbiology and outcome of hospital-acquired thoracic empyema (HATE) in adults.Methods:From December 2001 to December 2006, 459 adult patients with a diagnosis of thoracic empyema in a tertiary hospital were screened for HATE. HATE was defined as a new pleural empyema which developed after 48 hours of hospitalization.Results:In total, 56 adult (≧18 years) patients who were diagnosed with HATE were enrolled in our series, including 35 men (62.5%) and 21 women (37.5%), with ages ranging from 22 to 87 years old (mean = 59). Causes of HATE were classified into two categories: hospital-acquired pneumonia (HAP) related (n = 25) and non-HAP related (n = 31). Causes of non-HAP related empyema were comprised of catheter-related infections (n = 20), hepatobiliary tract infections (n = 6), septic emboli (n = 4), and postpneumonectomy (n = 1). Comparing the bacteriology between the two categories, HAP-related empyema had a significantly higher incidence of aerobic Gram-negative organisms (76% vs. 38.7%, P = 0.005), polymicrobial pathogens (40% vs. 9.7%, P = 0.008), and anaerobic pathogens (20% vs. 0%, P = 0.009) than non-HAP related empyema. However, there was no significant difference in mortality rate (60% vs. 52%, P = 0.52) between the two categories.Conclusions:Choice of antibiotic treatment for HATE should be based on the etiology of the pleural infection. In treating HAP-related empyema, antibiotics should cover aerobic Gram-negative, polymicrobial, and anaerobic pathogens.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1.Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med 1980;69:507–512.LightRW]]GirardWM]]JenkinsonSG&etal;Parapneumonic effusions.Am J Med198069507-5122.Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006;3:75–80.LightRWParapneumonic effusions and empyema.Proc Am Thorac Soc2006375-803.Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis 1993;148:813–817.SahnSAManagement of complicated parapneumonic effusions.Am Rev Respir Dis1993148813-8174.Davies CW, Gleeson FV, Davies RJ; Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of pleural infection. Thorax 2003;58(suppl 2):ii18–ii28.DaviesCW]]GleesonFV]]DaviesRJPleural Diseases GroupStandards of Care CommitteeBritish Thoracic SocietyBTS guidelines for the management of pleural infection.Thorax200358ii18-ii285.Davies CW, Kearney SE, Gleeson FV, et al. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999;160:1682–1687.DaviesCW]]KearneySE]]GleesonFV&etal;Predictors of outcome and long-term survival in patients with pleural infection.Am J Respir Crit Care Med19991601682-16876.Ferguson AD, Prescott RJ, Selkon JB, et al. The clinical course and management of thoracic empyema. QJM 1996;89:285–289.FergusonAD]]PrescottRJ]]SelkonJB&etal;The clinical course and management of thoracic empyema.QJM199689285-2897.Tsai TH, Jerng JS, Chen KY, et al. Community-acquired thoracic empyema in older people. J Am Geriatr Soc 2005;53:1203–1209.TsaiTH]]JerngJS]]ChenKY&etal;Community-acquired thoracic empyema in older people.J Am Geriatr Soc2005531203-12098.Ahmed RA, Marrie TJ, Huang JQ. Thoracic empyema in patients with community-acquired pneumonia. Am J Med 2006;119:877–883.AhmedRA]]MarrieTJ]]HuangJQThoracic empyema in patients with community-acquired pneumonia.Am J Med2006119877-8839.Liang SJ, Chen W, Lin YC, et al. Community-acquired thoracic empyema in young adults. South Med J 2007;100:1075–1080.LiangSJ]]ChenW]]LinYC&etal;Community-acquired thoracic empyema in young adults.South Med J20071001075-108010.Maskell NA, Batt S, Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006;174:817–823.MaskellNA]]BattS]]HedleyEL&etal;The bacteriology of pleural infection by genetic and standard methods and its mortality significance.Am J Respir Crit Care Med2006174817-82311.Heffner JE, Brown LK, Barbieri C, et al. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med 1995;151:1700–1708.HeffnerJE]]BrownLK]]BarbieriC&etal;Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis.Am J Respir Crit Care Med19951511700-170812.Lynch JP III. Hospital-acquired pneumonia: risk factors, microbiology, and treatment. Chest 2001;119:373S–384SLynchJPIIIHospital-acquired pneumonia: risk factors, microbiology, and treatment.Chest2001119373S-384S13.Kollef MH. What is ventilator-associated pneumonia and why is it important? Respir Care 2005;50:714–721; discussion 721–714.14.El Solh AA, Alhajjhasan A, Ramadan FH, et al. A comparative study of community- and nursing home-acquired empyema thoracis. J Am Geriatr Soc 2007;55:1847–1852.El SolhAA]]AlhajjhasanA]]RamadanFH&etal;A comparative study of community- and nursing home-acquired empyema thoracis.J Am Geriatr Soc2007551847-185215.Mansharamani NG, Koziel H. Chronic lung sepsis: lung abscess, bronchiectasis, and empyema. Curr Opin Pulm Med 2003;9:181–185.MansharamaniNG]]KozielHChronic lung sepsis: lung abscess, bronchiectasis, and empyema.Curr Opin Pulm Med20039181-18516.Sexauer WP, Quezado Z, Lippmann ML, et al. Pleural effusions in right-sided endocarditis: characteristics and pathophysiology. South Med J 1992;85:1176–1180.SexauerWP]]QuezadoZ]]LippmannML&etal;Pleural effusions in right-sided endocarditis: characteristics and pathophysiology.South Med J1992851176-118017.Lee KT, Sheen PC, Chen JS, et al. Pyogenic liver abscess: multivariate analysis of risk factors. World J Surg 1991;15:372–376; discussion 376–377.18.Lee KT, Wong SR, Sheen PC. Pyogenic liver abscess: an audit of 10 years’ experience and analysis of risk factors. Dig Surg 2001;18:459–465; discussion 465–456.19.Chen W, Chen CH, Chiu KL, et al. Clinical outcome and prognostic factors of patients with pyogenic liver abscess requiring intensive care. Crit Care Med 2008;36:1184–1188.ChenW]]ChenCH]]ChiuKL&etal;Clinical outcome and prognostic factors of patients with pyogenic liver abscess requiring intensive care.Crit Care Med2008361184-118820.Gossot D, Stern JB, Galetta D, et al. Thoracoscopic management of postpneumonectomy empyema. Ann Thorac Surg 2004;78:273–276.GossotD]]SternJB]]GalettaD&etal;Thoracoscopic management of postpneumonectomy empyema.Ann Thorac Surg200478273-27621.Kacprzak G, Marciniak M, Addae-Boateng E, et al. Causes and management of postpneumonectomy empyemas: our experience. Eur J Cardiothorac Surg 2004;26:498–502.KacprzakG]]MarciniakM]]Addae-BoatengE&etal;Causes and management of postpneumonectomy empyemas: our experience.Eur J Cardiothorac Surg200426498-50222.Kofteridis DP, Papadakis JA, Bouros D, et al. Nosocomial lower respiratory tract infections: prevalence and risk factors in 14 Greek hospitals. Eur J Clin Microbiol Infect Dis 2004;23:888–891.KofteridisDP]]PapadakisJA]]BourosD&etal;Nosocomial lower respiratory tract infections: prevalence and risk factors in 14 Greek hospitals.Eur J Clin Microbiol Infect Dis200423888-89123.Tu CY, Hsu WH, Hsia TC, et al. The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit. Intensive Care Med 2006;32:570–576.TuCY]]HsuWH]]HsiaTC&etal;The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit.Intensive Care Med200632570-57624.Lin YC, Chen HJ, Liu YH, et al. A 30-month experience of thoracic empyema in a tertiary hospital: emphasis on differing bacteriology and outcome between the medical intensive care unit (MICU) and medical ward. South Med J 2008;101:484–489.LinYC]]ChenHJ]]LiuYH&etal;A 30-month experience of thoracic empyema in a tertiary hospital: emphasis on differing bacteriology and outcome between the medical intensive care unit (MICU) and medical ward.South Med J2008101484-48925.Fry AM, Shay DK, Holman RC, et al. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988–2002. JAMA 2005;294:2712–2719.FryAM]]ShayDK]]HolmanRC&etal;Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988–2002.JAMA20052942712-271926.Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146–155.IbrahimEH]]ShermanG]]WardS&etal;The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.Chest2000118146-155
